Table 1 TCGA Clinicopathological Information
| Â | WHO II(%) | WHO III(%) | WHO IV(%) |
|---|---|---|---|
Number | |||
| Â | 196 | 215 | 146 |
Gender | |||
 Male | 105(54%) | 122(57%) | 94(64%) |
 Female | 91(46%) | 93(43%) | 52(36%) |
Age | |||
|  | 40.63 ± 0.93 | 45.79 ± 0.88 | 60.01 ± 1.093 |
IDH mutation | |||
 Mutant | 180(92%) | 154(72%) | 9(6%) |
 Wildtype | 14(7%) | 61(28%) | 133(91%) |
 NA | 2(1%) | 0(0%) | 4(3%) |
1p19q codeletion | |||
 Codel | 76(39%) | 62(29%) | 0(0%) |
 Non-codel | 120(61%) | 153(71%) | 141(97%) |
 NA | 0(0%) | 0(0%) | 5(3%) |
Median Survival Time | |||
| Â | 540 | 465 | 287 |
Censor | |||
 Alive | 174(89%) | 158(73%) | 52(36%) |
 Dead | 22(11%) | 57(27%) | 94(64%) |
 NA | 0(0%) | 0(0%) | 0(0%) |